GeoVax’s stock soars 54% to lead rally in companies developing mpox treatments
A competing company’s mpox vaccine failed to meet its primary endpoint.
A competing company’s mpox vaccine failed to meet its primary endpoint.
Beauty company’s projected 2025 adjusted earnings misses analyst estimates.
The market’s “Mr. Serenity” on why we should chill out about volatility, timing and “buying the dip.”
Oil futures fell Monday, unable to shake off worries about the demand outlook as investors continue to monitor Middle East tensions.
Democrats and Republicans backing an expanded CTC will help workers and the U.S. economy.
Shares of Lineage rose as a slew of analysts initiated coverage of the cold-storage-warehouse company, which recently went public.
Post Content
BARR pattern breakout signals a potential 40% rise to $9.50 for Toncoin (TON). Binance listing and Injective integration boost Toncoin’s price and liquidity. Bitcoin Dogs’...
A poll of business economics finds support for increasing legal U.S. immigration but also increasing border enforcement.